Eimskip: Transaction in relation to a share buy-back program

Eimskip: Transaction in relation to a share buy-back program

In week 46 2025 Eimskip purchased 175,000 of its own shares, at a purchase price of ISK 49,945,000 as further stipulated below:

The trade is in accordance with Eimskip‘s buy-back program as published on Nasdaq Iceland on 29 September 2025. The number of shares to be acquired under the buy-back program will be up to 2,250,000, at a total purchase price which may not exceed ISK 750,000,000. The buy-back program is in effect for 18 months post the Annual General Meeting held 27 March 2025, unless the conditions for maximum purchase are met before that time.

Under current buy-back program Eimskip has purchased a total of 1,074,680 shares in the company, with a total purchase price is ISK 358,498,000.

Eimskip held 2,625,000 shares prior to the notified transactions, and holds 2,800,000 after them, or the equivalent of 1.69% of issued shares in the company.

The execution of the buy-back program must comply with the Act on Public Limited Companies, No. 2/1995. In addition, the buy-back program will be implemented in accordance with Regulation (EU) No. 596/2014 on market abuse, as well as Commission Delegated Regulation (EU) 2016/1052 with regard to regulatory technical standards for the conditions applicable to buy-back programmes, and the Icelandic Act on Measures Against Market Abuse No. 60/2021.

For further information please contact
Guðbjörg Birna Björnsdóttir, Head of Treasury and Investor Relations, tel: +354 844 4752, email:  [email protected]

You May Also Be Interested In

• CGA.vitaslim Announces Mission to Help 5,000 Adults Combat the "Three Highs" and Reclaim Their Health and Wealth in Hong Kong
• Equinor ASA: Share buy-back – second tranche for 2026
• Orion Pharma’s ODM-212 Granted Orphan Designation for the Treatment of Malignant Mesothelioma by the European Commission